State Street Health Care Select Sector SPDR ETF
XLV
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 1 Iron Street Boston MA United States of America 2210
- IPO Date
- Dec 22, 1998
- CIK
- 0001064641
- Website
- ssga.com
- Similar Companies
- Business
- State Street Health Care Select Sector SPDR ETF (XLV) is an exchange-traded fund that seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index, which includes health care companies from the S&P 500 Index; the fund employs a replication strategy, investing substantially all of its assets in the securities comprising the index or depositary receipts representing those securities, weighted by market capitalization. The ETF holds approximately 63 stocks across subsectors such as pharmaceuticals (e.g., Eli Lilly and Company at 14.91%, Johnson & Johnson at 9.11%, AbbVie at 7.09%, Merck & Co. at 4.42%, Pfizer at 2.65%), health care providers and services (e.g., UnitedHealth Group at 5.45%), health care equipment and supplies (e.g., Abbott Laboratories at 3.95%), biotechnology, life sciences tools and services (e.g., Thermo Fisher Scientific at 3.84%), and health care technology (e.g., Intuitive Surgical at 3.54%, Amgen at 3.09%); top 10 holdings account for about 58% of assets under management, with total AUM exceeding $40 billion as of late 2025. Launched on December 16, 1998, and issued by State Street Investment Management (formerly State Street Global Advisors, rebranded in June 2025 to reflect expanded solutions and strategic growth), the ETF is domiciled in the United States with headquarters in Boston, Massachusetts, and trades primarily on U.S. exchanges for institutional and retail investors seeking targeted exposure to the U.S. health care sector. In recent developments, State Street Investment Management assumed distribution and marketing responsibilities for the Select Sector SPDR ETFs, including XLV, enhancing operational control since inception; the firm also announced plans to close certain underperforming ETFs amid portfolio optimization, while XLV continues to attract inflows amid sector momentum from biotech M&A activity and innovation tailwinds. The ETF maintains a low expense ratio of 0.08%, quarterly dividend distributions (yielding approximately 1.58% trailing twelve months), and serves global investors through platforms available in markets including the United States and Mexico.